On Air Now

Listen

Listen Live Now » 100.3 FM Green Bay, WI

Weather

Current Conditions(Green Bay,WI 54303)

More Weather »
62° Feels Like: 62°
Wind: WSW 0 mph Past 24 hrs - Precip: 0”
Current Radar for Zip

Tonight

Clear 57°

Tomorrow

Scattered Thunderstorms 79°

Sat Night

Thunderstorms Early 57°

Alerts

AstraZeneca signs deal on cancer drugs with Immunocore

LONDON (Reuters) - AstraZeneca has signed a deal with private British biotech company Immunocore to boost its experimental cancer drug pipeline as it seeks to find new medicines to replace those going off patent.

Immunocore is developing drugs known as "ImmTACs" that exploit the power of the body's own immune system to find and kill diseased cells.

AstraZeneca said on Wednesday its MedImmune unit would pay Immunocore $20 million upfront per program and the biotech firm would then be eligible to get up to $300 million in development and commercial milestone payments for each target program, plus royalties on any eventual sales.

(Reporting by Ben Hirschler)

Comments